FIT Combining FC for Predicting MH and Histology Remission in UC

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05447572

Enrollment

300

Registered

2022-07-07

Start date

2021-09-01

Completion date

2023-12-12

Last updated

2022-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fecal Calprotetin, FIT, Histology Remission, Mucosal Healing, Ulcerative Colitis

Brief summary

Investigaters will perform a clinical trial to asess the abilitiy of qFIT and FC on predicting UC MH and histology remission.

Interventions

OTHERFIT + FC

FIT + FC

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Ulcerative colitis patients.

Exclusion criteria

* GI bleeding

Design outcomes

Primary

Measure	Time frame	Description
diagnostic value of FIT and/without FC on predicting MH	2 weeks	diagnostic value of FIT and/without FC on predicting MH, Mayo score will be used.

Countries

China

Contacts

Primary ContactYan Zhang, DOC

qlzhangyan@qq.com+86-18560089821

Backup ContactYihao Song, DOC

781975756@qq.com+86-13165133773

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026